This Article Full Text Full Text (PDF) All Versions of this Article: 34/6/1526    most recent 01.STR.0000070841.31224.29v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zausinger, S. Articles by Schmid-Elsaesser, R. Search for Related Content PubMed PubMed Citation Articles by Zausinger, S. Articles by Schmid-Elsaesser, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB D-MANNITOL DEXAMETHASONE MAGNESIUM COMPOUNDS MAGNESIUM, ELEMENTAL Medline Plus Health Information Transient Ischemic Attack Related Collections Animal models of human disease Acute Cerebral Infarction Other Stroke Treatment - Medical Aneurysm, AVM, hematoma

(Stroke. 2003;34:1526.)
© 2003 American Heart Association, Inc.

Original Contributions

Neuroprotection in Transient Focal Cerebral Ischemia by Combination Drug Therapy and Mild Hypothermia

Comparison With Customary Therapeutic Regimen

Stefan Zausinger, MD; Thomas Westermaier, MD; Nikolaus Plesnila, MD; Hans-Jakob Steiger, MD, PhD Robert Schmid-Elsaesser, MD, PhD

From the Department of Neurosurgery (S.Z., T.W., H-J.S., R.S-E.) and Institute for Surgical Research (N.P.), Ludwig-Maximilians University, Klinikum Grosshadern, Munich, Germany.

Correspondence to Dr Stefan Zausinger, Department of Neurosurgery, Ludwig-Maximilians University, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany. E-mail Stefan.Zausinger{at}nc.med.uni-muenchen.de

Background and Purpose— A combined therapeutic approach has been advocated repeatedly for treatment of focal cerebral ischemia. A clinical example of combined therapy is administration of nimodipine, mannitol, dexamethasone, and barbiturates during temporary occlusion of a cerebral artery in neurovascular surgery. We have recently demonstrated outstanding neuroprotective properties of a combination therapy with magnesium (calcium antagonist and glutamate antagonist), tirilazad (antioxidant), and mild hypothermia (MTH). In this study we compared this treatment strategy with the customary treatment options in a rat model of transient focal cerebral ischemia.

Methods— Sprague-Dawley rats (n=120) were subjected to 90 minutes of middle cerebral artery occlusion by an intraluminal filament (n=10 per group). In experiment 1, the customary treatment options (nimodipine, mannitol, dexamethasone, methohexital) were evaluated as monotherapy and in combination. In experiment 2, the customary and the new combination therapy (MTH) were compared. Mild hypothermia (33°C) was maintained for 2 hours. Neurological examinations were performed daily. Infarct size was assessed histologically after 7 days.

Results— In experiment 1, infarct volume was attenuated by 34% at maximum, with mannitol and methohexital being the most effective drugs given as monotherapy. In experiment 2, combined administration of the customary treatment options had no additive effect (infarct volume -36%). Combination therapy with MTH reduced total infarction by 73% and almost completely abolished cortical infarction (-91%). None of the animals of this group had any residual neurological deficit at the end of the observation period (P<0.05 versus all other groups).

Conclusions— The efficacy of drugs (monotherapy or in combination) most commonly used for neuroprotection during neurovascular surgery is limited. The newly proposed combination therapy (magnesium, tirilazad, and mild hypothermia), which is based on pathophysiological considerations, seems to be a promising alternative for neuroprotection in cerebrovascular surgery.

Key Words: cerebral ischemia, focal • drug therapy, combination • hypothermia • laser-Doppler flowmetry • neuroprotection

This article has been cited by other articles:

				M.M. Binda and P.R. Koninckx Prevention of adhesion formation in a laparoscopic mouse model should combine local treatment with peritoneal cavity conditioning Hum. Reprod., June 1, 2009; 24(6): 1473 - 1479. [Abstract] [Full Text] [PDF]

				E. Sena, P. Wheble, P. Sandercock, and M. Macleod Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke Stroke, February 1, 2007; 38(2): 388 - 394. [Abstract] [Full Text] [PDF]

				P. Macchiarini, H. Kamiya, C. Hagl, M. Winterhalter, J. Barbera, M. Karck, J. Pomar, and A. Haverich Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required? Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 237 - 241. [Abstract] [Full Text] [PDF]

				G. M. Tong and R. K. Rude Magnesium Deficiency in Critical Illness J Intensive Care Med, January 1, 2005; 20(1): 3 - 17. [Abstract] [PDF]

				Y. Liu, J. D. Barks, G. Xu, and F. S. Silverstein Topiramate Extends the Therapeutic Window for Hypothermia-Mediated Neuroprotection After Stroke in Neonatal Rats Stroke, June 1, 2004; 35(6): 1460 - 1465. [Abstract] [Full Text] [PDF]